C J Bulpitt

3.8k total citations
97 papers, 2.8k citations indexed

About

C J Bulpitt is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, C J Bulpitt has authored 97 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in C J Bulpitt's work include Blood Pressure and Hypertension Studies (29 papers), Cardiovascular Health and Disease Prevention (7 papers) and Glaucoma and retinal disorders (6 papers). C J Bulpitt is often cited by papers focused on Blood Pressure and Hypertension Studies (29 papers), Cardiovascular Health and Disease Prevention (7 papers) and Glaucoma and retinal disorders (6 papers). C J Bulpitt collaborates with scholars based in United Kingdom, Belgium and United States. C J Bulpitt's co-authors include C. T. Dollery, M G Everitt, C. Hodes, Eva M. Kohner, Stuart Carne, Astrid Fletcher, AE Fletcher, M Shipley, A Amery and Jan A. Staessen and has published in prestigious journals such as Circulation, Diabetes Care and The American Journal of Medicine.

In The Last Decade

C J Bulpitt

96 papers receiving 2.5k citations

Peers

Countries citing papers authored by C J Bulpitt

Since Specialization

Citations

This map shows the geographic impact of C J Bulpitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Bulpitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Bulpitt more than expected).

Fields of papers citing papers by C J Bulpitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C J Bulpitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Bulpitt. The network helps show where C J Bulpitt may publish in the future.

Co-authorship network of co-authors of C J Bulpitt

This figure shows the co-authorship network connecting the top 25 collaborators of C J Bulpitt. A scholar is included among the top collaborators of C J Bulpitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C J Bulpitt. C J Bulpitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	114Estimating individual cardiovascular disease risk reduction by blood pressure lowering in elderly patients: results from the HYVET study 2018 ·European Heart Journal ·Tamar I. de Vries, Ruth Peters, Nigel Beckett, Jannick A N Dorresteijn, Jan Westerink, Mariëlle H. Emmelot‐Vonk, Majon Muller, Y. van der Graaf, C J Bulpitt, Frank L.J. Visseren	1
2	Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial 2012 ·Age and Ageing ·Ruth Peters, Nigel Beckett, Ruth Poulter, (unknown), Krzysztof Narkiewicz, R. Fagard, Dorothea Nitsch, Ning Wang, (unknown), Astrid Fletcher, C J Bulpitt	16
3	Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET 2009 ·Age and Ageing ·Ruth Peters, Nigel Beckett, (unknown), (unknown), Fuer Lu, Ruth Poulter, Nicola Gainsborough, (unknown), M.C. de Vernejoul, Astrid Fletcher, C J Bulpitt	31
4	Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects 2008 ·Journal of Human Hypertension ·Riitta Antikaínen, Tomasz Grodzicki, DG Beevers, John Webster, Jari Jokelainen, C J Bulpitt	9
5	Left ventricular hypertrophy determined by Sokolow–Lyon criteria: a different predictor in women than in men? 2006 ·Journal of Human Hypertension ·Riitta Antikaínen, Tomasz Grodzicki, Andrew Palmer, DG Beevers, John Webster, C J Bulpitt	22
6	Area deprivation, social class, and quality of life among people aged 75 years and over in Britain 2005 ·International Journal of Epidemiology ·Elizabeth Breeze, Daniel A. Jones, Paul Wilkinson, C J Bulpitt, Chris Grundy, (unknown), AE Fletcher	67
7	The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848] 2002 ·BMC Health Services Research ·AE Fletcher, Daniel A. Jones, C J Bulpitt, (unknown)	66
8	Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP) 2000 ·Journal of Human Hypertension ·Mark Stahl, C J Bulpitt, Andrew Palmer, DG Beevers, (unknown), John Webster	21
9	Peripheral arterial compliance is lower in Afro-Caribbeans compared to white Caucasians with type 2 diabetes after adjustment for blood pressure 1999 ·Journal of Human Hypertension ·Chakravarthi Rajkumar, (unknown), Karim Meeran, (unknown), C J Bulpitt	16
10	Symptoms reported by elderly patients with isolated systolic hypertension: baseline data from the SYST-EUR trial. Systolic Hypertension in Europe 1999 ·Age and Ageing ·C J Bulpitt	25
11	The effect of age on vascular compliance in man: which are the appropriate measures? 1999 ·Journal of Human Hypertension ·C J Bulpitt, James D. Cameron, C. Rajkumar, (unknown), Martin J. Connor, J Joshi, D. Lyons, (unknown), Petros Nihoyannopoulos	33
12	A questionnaire to assess risk factors, quality of life, and use of health resources in patients with venous disease. 1992 ·PubMed ·Peter Franks, Debra D. Wright, Astrid Fletcher, Christine Moffatt, (unknown), C J Bulpitt, Charles McCollum	30
13	The progress of the visual field in chronic simple glaucoma and ocular hypertension treated topically with pilocarpine or with timolol 1990 ·Eye ·Ronald P. Crick, (unknown), M Shipley, (unknown), C J Bulpitt	9
14	Blood Cadmium in London Civil Servants 1990 ·International Journal of Epidemiology ·Jan A. Staessen, W. B. Yeoman, A. E. Fletcher, Hugh L.J. Markowe, Michael Marmot, G A Rose, A Semmence, M Shipley, C J Bulpitt	19
15	The visual field in chronic simple glaucoma and ocular hypertension; its character, progress, relationship to the level of intraocular pressure and response to treatment 1989 ·Eye ·Ronald P. Crick, Roger Vogel, (unknown), M Shipley, (unknown), (unknown), C J Bulpitt	31
16	The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). 1988 ·PubMed ·Astrid Fletcher, D G Beevers, C J Bulpitt, (unknown), (unknown), Dereck Hunt, A. D. Munro‐Faure, R B Newson, (unknown), (unknown)	56
17	Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomised controlled trial. 1984 ·BMJ ·R J Heddle, J F Soothill, C J Bulpitt, David J. Atherton	40
18	Atenolol and chlorthalidone in combination for hypertension. 1979 ·British Journal of Clinical Pharmacology ·D. Nicholas Bateman, (unknown), JC Mucklow, C J Bulpitt, C. T. Dollery	22
19	Antihypertensive Therapy in Elderly Patients 1977 ·Gerontology ·A Amery, P Berthaux, W. H. Birkenhäger, C J Bulpitt, D Clement, A. De Schaepdryver, C. T. Dollery, (unknown), R. Fagard, F Forette, Jan Hellemans, (unknown), P Lund‐Johansen, J.-C. Meurice, (unknown)	14
20	Computer-based Hypertension Clinic Records: A Co-operative Study 1974 ·BMJ ·Lawrence J. Beilin, C J Bulpitt, E C Coles, C. T. Dollery, Brian F. G. Johnson, (unknown), A. D. Munro‐Faure, (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact